Evidence map›Paper›PMID 30127653›Full record

ArticlePragmatic and observational research2018

Performance of database-derived severe exacerbations and asthma control measures in asthma: responsiveness and predictive utility in a UK primary care database with linked questionnaire data.

Gene Colice, Alison Chisholm, Alexandra L Dima, Helen K Reddel, Annie Burden, Richard J Martin, Guy Brusselle, Todor A Popov, Julie von Ziegenweidt, David B Price

Open access · diamondAbstract read
In one paragraph

Article in Pragmatic and observational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 7 countries.

Gene ColiceGlobal Medicines Development, AstraZeneca, Gaithersburg, MD, USA.
Alison ChisholmRespiratory Effectiveness Group, Cambridge, UK.
Alexandra L DimaHealth Services and Performance Research EA 7425 HESPER, Université Claude Bernard Lyon 1, Lyon, France.
Helen K ReddelClinical Management Group, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia.
Annie BurdenObservational and Pragmatic Research Institute Pte Ltd, Singapore, Singapore, dprice@opri.sg.
Richard J MartinDepartment of Medicine, National Jewish Health, University of Colorado School of Medicine, Denver, CO, USA.
Guy BrusselleDepartment of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Todor A PopovDepartment Allergology, University Hospital "Sv. Ivan Rilski", Sofia, Bulgaria.
Julie von ZiegenweidtDepartment of Haematology, University of Cambridge, Cambridge, UK.
David B PriceObservational and Pragmatic Research Institute Pte Ltd, Singapore, Singapore, dprice@opri.sg.
AstraZeneca (United States) · USGhent University Hospital · BENational Jewish Health · USObservational & Pragmatic Research Institute · SGThe University of Sydney · AUUniversité Claude Bernard Lyon 1 · FRUniversity Hospital St. Ivan Rilski · BGUniversity of Aberdeen · GBUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObservational research is essential to evaluate the real-life effectiveness of asthma treatments and can now make use of outcomes derived from electronic medical records.

aimThe aim of this study was to investigate the utility of several database outcome measures in asthma.

methodsThis study identified cohorts of patients with active asthma from a UK primary care database - Optimum Patient Care Research Database - approximately 10% of which was prospectively supplemented with questionnaire data. The "Questionnaire cohort" included patients aged 18-60 years with valid questionnaire data and 1 year of continuous primary care data. Separate "ICS initiation" and "ICS step-up" cohorts included patients aged 5-60 years initiated on inhaled corticosteroids (ICSs), who had 1 year of continuous primary care data before, and after, this index visit. Database measures of asthma symptom control and exacerbations were identified in the Optimum Patient Care Research Database and cross-tabulated with corresponding patient-reported (questionnaire) data. Responsiveness of the database outcomes was analyzed, using McNemar's and Wilcoxon's signed rank tests, and Poisson regression was used to estimate the association between database outcomes and future risk of database exacerbations, in the ICS initiation cohort.

resultsThe final study included 2,366 Questionnaire cohort patients and 51,404 ICS initiation patients. Agreement between patient-reported and database-recorded exacerbations was fair (kappa 0.35). Following the initiation of ICS, database risk domain asthma control (based on exacerbations) improved (proportion of patients with uncontrolled asthma decreased from 24.9% to 18.6%;

conclusionAsthma control and exacerbations derived from primary care databases were responsive, with the exception of short-acting beta-agonist prescriptions, and useful for risk prediction.

Indexed as

asthma controlasthma exacerbationselectronic health recordsreal-life effectivenessvalidation study

Identifiers

PMID30127653
PMCPMC6092127
OpenAlexW2886382206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.